Omega Alpha SPAC (Omega Alpha SPAC) ROCE % : -0.56% (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Omega Alpha SPAC ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Omega Alpha SPAC's annualized ROCE % for the quarter that ended in Sep. 2022 was -0.56%.

Omega Alpha SPAC ROCE % Historical Data

The historical data trend for Omega Alpha SPAC's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omega Alpha SPAC ROCE % Chart

Omega Alpha SPAC Annual Data

Trend

Dec20

Dec21

ROCE %

-1.22

Omega Alpha SPAC Quarterly Data
	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
ROCE %	Get a 7-Day Free Trial			-0.50	-0.53	-0.80	-0.46	-0.56

Omega Alpha SPAC ROCE % Calculation

Omega Alpha SPAC's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	-0.845	/	( ( (0.399 - 0.407)	+	(138.927 - 0.055) )	/ 2 )
	=	-0.845	/	( (-0.008	+	138.872)	/ 2 )
	=	-0.845	/	69.432
	=	-1.22 %

Omega Alpha SPAC's ROCE % of for the quarter that ended in Sep. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2022 )		(Q: Jun. 2022 )		(Q: Sep. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2022 )		(Q: Jun. 2022 )		(Q: Sep. 2022 )
	=	-0.784	/	( ( (138.633 - 0.008)	+	(139.081 - 0.043) )	/ 2 )
	=	-0.784	/	( ( 138.625	+	139.038 )	/ 2 )
	=	-0.784	/	138.8315
	=	-0.56 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2022) EBIT data.

Omega Alpha SPAC (NAS:OMEG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Omega Alpha SPAC ROCE % Related Terms

Thank you for viewing the detailed overview of Omega Alpha SPAC's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Omega Alpha SPAC (Omega Alpha SPAC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Omega Alpha SPAC (NAS:OMEG) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

888 Boylston Street, Suite 1111, Boston, MA, USA, 02199

Website

Omega Alpha SPAC is a blank check company.

Executives

Otello Stampacchia	director, 10 percent owner, officer: Chief Executive Officer	888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Alpha Management Omega	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02119
Joseph P Slattery	director	C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Martin Babler	director	C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Daniel Lynch	director
Vincent Ossipow	officer: Chief Scientific Officer	CH. DES VIGNES 1, COMMUGNY V8 1291
Van De Winkel Jan	director	C/O HOOKIPA PHARMA INC., 430 EAST 29TH STREET 14TH FLOOR, NEW YORK NY 10016
Omega Fund Vi, L.p.	10 percent owner	888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp Manager, Ltd.	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp, L.p.	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Michelle Doig	director, officer: President	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Francesco Draetta	officer: Chief Financial Officer	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Alexandra Pearsall	10 percent owner	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199

Omega Alpha SPAC (Omega Alpha SPAC) Headlines

From GuruFocus

Omega Alpha Spac (OMEG) CEO Otello Stampacchia Bought $5 million of Shares

By GuruFocus Research GuruFocus Editor • 01-14-2021

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

By Business Wire Business Wire • 01-07-2021